Friedman Center for Nutrition & Inflammation
Found 78 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is A  [Clear All Filters]
2024
Abramson J, Dobeš J, Lyu M, Sonnenberg GF.  2024.  The emerging family of RORγt+ antigen-presenting cells.. Nat Rev Immunol. 24(1):64-77.
2023
Hill AA, Kim M, Zegarra-Ruiz DF, Chang L-C, Norwood K, Assié A, Wu W-JH, Renfroe MC, Song HWong, Major AM et al..  2023.  Acute high-fat diet impairs macrophage-supported intestinal damage resolution.. JCI Insight. 8(3)
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Wheeler MA, Clark IC, Lee H-G, Li Z, Linnerbauer M, Rone JM, Blain M, Akl CFaust, Piester G, Giovannoni F et al..  2023.  Droplet-based forward genetic screening of astrocyte-microglia cross-talk.. Science. 379(6636):1023-1030.
Topczewska PM, Rompe ZA, Jakob MO, Stamm A, Leclère PS, Preußer A, Duerr CU, Thole LMarie Laur, Kotsch K, Artis D et al..  2023.  ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.. Front Immunol. 14:1130933.
Awasthi D, Chopra S, Cho BA, Emmanuelli A, Sandoval TA, Hwang S-M, Chae C-S, Salvagno C, Tan C, Vasquez-Urbina L et al..  2023.  Inflammatory ER stress responses dictate the immunopathogenic progression of systemic candidiasis.. J Clin Invest. 133(17)
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Gainullina A, Mogilenko DA, Huang L-H, Todorov H, Narang V, Kim K-W, Yng LSheau, Kent A, Jia B, Seddu K et al..  2023.  Network analysis of large-scale ImmGen and Tabula Muris datasets highlights metabolic diversity of tissue mononuclear phagocytes.. Cell Rep. 42(2):112046.
Kim B, Rothenberg ME, Sun X, Bachert C, Artis D, Zaheer R, Deniz Y, Rowe P, Cyr S.  2023.  Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.. J Allergy Clin Immunol.
Smith ES, Chen J, Pan Y, Mahtani P, Lukin D, Ahmed W, Longman R, Burakoff R, Scherl E, Battat R.  2023.  The Relationship Between the Endoscopic Healing Index, Fecal Calprotectin, and Magnetic Resonance Enterography in Crohn's Disease.. J Clin Gastroenterol.
2022
Skovsø S, Panzhinskiy E, Kolic J, Cen HHoward, Dionne DA, Dai X-Q, Sharma RB, Elghazi L, Ellis CE, Faulkner K et al..  2022.  Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.. Nat Commun. 13(1):735.
Ahmed W, Galati J, Kumar A, Christos PJ, Longman R, Lukin DJ, Scherl E, Battat R.  2022.  Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.. Clin Gastroenterol Hepatol. 20(3):e361-e379.
Nwosu BUdoka, Parajuli S, Jasmin G, Fleshman J, Sharma RB, Alonso LC, Lee AF, Barton BA.  2022.  Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial.. J Endocr Soc. 6(1):bvab179.
Jin W-B, Li T-T, Huo D, Qu S, Li XV, Arifuzzaman M, Lima SF, Shi H-Q, Wang A, Putzel GG et al..  2022.  Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.. Cell. 185(3):547-562.e22.
Jin W-B, Li T-T, Huo D, Qu S, Li XV, Arifuzzaman M, Lima SF, Shi H-Q, Wang A, Putzel GG et al..  2022.  Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome.. Cell. 185(3):547-562.e22.
Zhou L, Zhou W, Joseph AM, Chu C, Putzel GG, Fang B, Teng F, Lyu M, Yano H, Andreasson KI et al..  2022.  Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation.. Nat Immunol. 23(2):251-261.
Leonardi I, Gao IH, Lin W-Y, Allen M, Li XV, Fiers WD, De Celie MBialt, Putzel GG, Yantiss RK, Johncilla M et al..  2022.  Mucosal fungi promote gut barrier function and social behavior via Type 17 immunity.. Cell.
Burnham P, Chen F, Cheng AP, Srivatana V, Zhang LT, Edusei E, Albakry S, Botticelli B, Guo X, Renaghan A et al..  2022.  Peritoneal Effluent Cell-Free DNA Sequencing in Peritoneal Dialysis Patients With and Without Peritonitis.. Kidney Med. 4(1):100383.
Battat R, Galati JS, Lukin D, Chabouni F, Sockolow R, Carter J, Fajardo K, Yang S, Reich J, Jacobs V et al..  2022.  A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease.. J Clin Gastroenterol. 56(3):e176-e182.
Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP et al..  2022.  Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.. Lancet Gastroenterol Hepatol. 7(1):69-95.
Pan Y, Ahmed W, Mahtani P, Wong R, Longman R, Lukin DJeremy, Scherl EJ, Battat R.  2022.  Utility of Therapeutic Drug Monitoring for Tumor Necrosis Factor Antagonists and Ustekinumab in Postoperative Crohn's Disease.. Inflamm Bowel Dis.